| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 1:845-867, 2002.
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
From The Plasma Proteome Institute, Washington, D. C. 20009-3450
The human plasma proteome holds the promise of a revolution in disease diagnosis and therapeutic monitoring provided that major challenges in proteomics and related disciplines can be addressed. Plasma is not only the primary clinical specimen but also represents the largest and deepest version of the human proteome present in any sample: in addition to the classical "plasma proteins," it contains all tissue proteins (as leakage markers) plus very numerous distinct immunoglobulin sequences, and it has an extraordinary dynamic range in that more than 10 orders of magnitude in concentration separate albumin and the rarest proteins now measured clinically. Although the restricted dynamic range of conventional proteomic technology (two-dimensional gels and mass spectrometry) has limited its contribution to the list of 289 proteins (tabulated here) that have been reported in plasma to date, very recent advances in multidimensional survey techniques promise at least double this number in the near future. Abundant scientific evidence, from proteomics and other disciplines, suggests that among these are proteins whose abundances and structures change in ways indicative of many, if not most, human diseases. Nevertheless, only a handful of proteins are currently used in routine clinical diagnosis, and the rate of introduction of new protein tests approved by the United States Food and Drug Administration (FDA) has paradoxically declined over the last decade to less than one new protein diagnostic marker per year. We speculate on the reasons behind this large discrepancy between the expectations arising from proteomics and the realities of clinical diagnostics and suggest approaches by which protein-disease associations may be more effectively translated into diagnostic tools in the future.
To whom correspondence should be addressed: The Plasma Proteome Inst., P.O. Box 53450, Washington, D. C. 20009-3450. Fax: 202-234-9175; E-mail: leighanderson{at}plasmaproteome.org
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Kipnis, K. Hansen, T. Sawa, K. Moriyama, A. Zurawel, A. Ishizaka, and J. Wiener-Kronish Proteomic Analysis of Undiluted Lung Epithelial Lining Fluid Chest, August 1, 2008; 134(2): 338 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hartmann, M. Schrenk, A. Dottinger, S. Nagel, J. Roeraade, T. O. Joos, and M. F. Templin Expanding Assay Dynamics: A Combined Competitive and Direct Assay System for the Quantification of Proteins in Multiplexed Immunoassays Clin. Chem., June 1, 2008; 54(6): 956 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Buckham Sporer, P. S. D. Weber, J. L. Burton, B. Earley, and M. A. Crowe Transportation of young beef bulls alters circulating physiological parameters that may be effective biomarkers of stress J Anim Sci, June 1, 2008; 86(6): 1325 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Berglund, J. Andrade, J. Odeberg, and M. Uhlen The epitope space of the human proteome Protein Sci., April 1, 2008; 17(4): 606 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Garbett, J. J. Miller, A. B. Jenson, and J. B. Chaires Calorimetry Outside the Box: A New Window into the Plasma Proteome Biophys. J., February 15, 2008; 94(4): 1377 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Merrick The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research Brief Funct Genomic Proteomic, February 12, 2008; (2008) eln004v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B.H. Williams, E. K.F. Chan, M. J. Cowley, and P. F.R. Little The influence of genetic variation on gene expression Genome Res., December 1, 2007; 17(12): 1707 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Keshishian, T. Addona, M. Burgess, E. Kuhn, and S. A. Carr Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution Mol. Cell. Proteomics, December 1, 2007; 6(12): 2212 - 2229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Seam, D. A. Gonzales, S. J. Kern, G. L. Hortin, G. T. Hoehn, and A. F. Suffredini Quality Control of Serum Albumin Depletion for Proteomic Analysis Clin. Chem., November 1, 2007; 53(11): 1915 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang and D. W. Chan Cancer Biomarker Discovery in Plasma Using a Tissue-targeted Proteomic Approach Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1915 - 1917. [Full Text] [PDF]
|
|
|
|
|
|
A. Prakash, B. Piening, J. Whiteaker, H. Zhang, S. A. Shaffer, D. Martin, L. Hohmann, K. Cooke, J. M. Olson, S. Hansen, et al. Assessing Bias in Experiment Design for Large Scale Mass Spectrometry-based Quantitative Proteomics Mol. Cell. Proteomics, October 1, 2007; 6(10): 1741 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stahl-Zeng, V. Lange, R. Ossola, K. Eckhardt, W. Krek, R. Aebersold, and B. Domon High Sensitivity Detection of Plasma Proteins by Multiple Reaction Monitoring of N-Glycosites Mol. Cell. Proteomics, October 1, 2007; 6(10): 1809 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Belluco, E. F. Petricoin, E. Mammano, F. Facchiano, S. Ross-Rucker, D. Nitti, C. Di Maggio, C. Liu, M. Lise, L. A. Liotta, et al. Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast Cancer Ann. Surg. Oncol., September 1, 2007; 14(9): 2470 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Picotti, R. Aebersold, and B. Domon The Implications of Proteolytic Background for Shotgun Proteomics Mol. Cell. Proteomics, September 1, 2007; 6(9): 1589 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Mason, T. M. Therneau, J. E. Eckel-Passow, K. L. Johnson, A. L. Oberg, J. E. Olson, K. S. Nair, D. C. Muddiman, and H. R. Bergen III A Method for Automatically Interpreting Mass Spectra of 18O-Labeled Isotopic Clusters Mol. Cell. Proteomics, February 1, 2007; 6(2): 305 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, A. Y. Liu, P. Loriaux, B. Wollscheid, Y. Zhou, J. D. Watts, and R. Aebersold Mass Spectrometric Detection of Tissue Proteins in Plasma Mol. Cell. Proteomics, January 1, 2007; 6(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sun, J. A. Ranish, A. G. Utleg, J. T. White, X. Yan, B. Lin, and L. Hood Shotgun Glycopeptide Capture Approach Coupled with Mass Spectrometry for Comprehensive Glycoproteomics Mol. Cell. Proteomics, January 1, 2007; 6(1): 141 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Nielsen, M. M. Savitski, and R. A. Zubarev Extent of Modifications in Human Proteome Samples and Their Effect on Dynamic Range of Analysis in Shotgun Proteomics Mol. Cell. Proteomics, December 1, 2006; 5(12): 2384 - 2391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kalenka, R. E. Feldmann Jr, K. Otero, M. H. Maurer, K. F. Waschke, and F. Fiedler Changes in the Serum Proteome of Patients with Sepsis and Septic Shock Anesth. Analg., December 1, 2006; 103(6): 1522 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Nalefski, C. M. D'Antoni, E. P. Ferrell, J. A. Lloyd, H. Qiu, J. L. Harris, and D. H. Whitney Single-molecule detection for femtomolar quantification of proteins in heterogeneous immunoassays. Clin. Chem., November 1, 2006; 52(11): 2172 - 2175. [Full Text] [PDF]
|
|
|
|
|
|
T. Liu, W.-J. Qian, H. M. Mottaz, M. A. Gritsenko, A. D. Norbeck, R. J. Moore, S. O. Purvine, D. G. Camp II, and R. D. Smith Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry Mol. Cell. Proteomics, November 1, 2006; 5(11): 2167 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Castronovo, D. Waltregny, P. Kischel, C. Roesli, G. Elia, J.-N. Rybak, and D. Neri A Chemical Proteomics Approach for the Identification of Accessible Antigens Expressed in Human Kidney Cancer Mol. Cell. Proteomics, November 1, 2006; 5(11): 2083 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Marguiles, V. S. Klimberg, S. Bhattacharrya, D. Gaddy, and L. J. Suva Genomics and Proteomics of Bone Cancer. Clin. Cancer Res., October 15, 2006; 12(20): 6217s - 6221s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zolg The Proteomic Search for Diagnostic Biomarkers: Lost in Translation? Mol. Cell. Proteomics, October 1, 2006; 5(10): 1720 - 1726. [Full Text] [PDF]
|
|
|
|
|
|
T. Liu, W.-J. Qian, M. A. Gritsenko, W. Xiao, L. L. Moldawer, A. Kaushal, M. E. Monroe, S. M. Varnum, R. J. Moore, S. O. Purvine, et al. High Dynamic Range Characterization of the Trauma Patient Plasma Proteome Mol. Cell. Proteomics, October 1, 2006; 5(10): 1899 - 1913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Sleat, Y. Wang, I. Sohar, H. Lackland, Y. Li, H. Li, H. Zheng, and P. Lobel Identification and Validation of Mannose 6-Phosphate Glycoproteins in Human Plasma Reveal a Wide Range of Lysosomal and Non-lysosomal Proteins Mol. Cell. Proteomics, October 1, 2006; 5(10): 1942 - 1956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mayr, J. Zhang, A. S. Greene, D. Gutterman, J. Perloff, and P. Ping Proteomics-based Development of Biomarkers in Cardiovascular Disease: Mechanistic, Clinical, and Therapeutic Insights Mol. Cell. Proteomics, October 1, 2006; 5(10): 1853 - 1864. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Jaffe, D. R. Mani, K. C. Leptos, G. M. Church, M. A. Gillette, and S. A. Carr PEPPeR, a Platform for Experimental Proteomic Pattern Recognition Mol. Cell. Proteomics, October 1, 2006; 5(10): 1927 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Singh and L. Johnson Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clin. Cancer Res., September 15, 2006; 12(18): 5312 - 5328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Barker, P. D. Wagner, S. E. Stein, D. M. Bunk, S. Srivastava, and G. S. Omenn Standards for Plasma and Serum Proteomics in Early Cancer Detection: A Needs Assessment Report from the National Institute of Standards and Technology-National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005 Clin. Chem., September 1, 2006; 52(9): 1669 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ono, M. Shitashige, K. Honda, T. Isobe, H. Kuwabara, H. Matsuzuki, S. Hirohashi, and T. Yamada Label-free Quantitative Proteomics Using Large Peptide Data Sets Generated by Nanoflow Liquid Chromatography and Mass Spectrometry Mol. Cell. Proteomics, July 1, 2006; 5(7): 1338 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Hortin The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome Clin. Chem., July 1, 2006; 52(7): 1223 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Hortin, S. A. Jortani, J. C. Ritchie Jr, R. Valdes Jr, and D. W. Chan Proteomics: A New Diagnostic Frontier Clin. Chem., July 1, 2006; 52(7): 1218 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, S.-l. Wu, and W. S. Hancock Approaches to the study of N-linked glycoproteins in human plasma using lectin affinity chromatography and nano-HPLC coupled to electrospray linear ion trap--Fourier transform mass spectrometry Glycobiology, June 1, 2006; 16(6): 514 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. C. Ru, L. A. Zhu, J. Silberman, and C. D. Shriver Label-free Semiquantitative Peptide Feature Profiling of Human Breast Cancer and Breast Disease Sera via Two-dimensional Liquid Chromatography-Mass Spectrometry Mol. Cell. Proteomics, June 1, 2006; 5(6): 1095 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Domon and R. Aebersold Mass spectrometry and protein analysis. Science, April 14, 2006; 312(5771): 212 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Anderson and C. L. Hunter Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins Mol. Cell. Proteomics, April 1, 2006; 5(4): 573 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Sin, S. F. P. Man, A. McWilliams, and S. Lam Progression of Airway Dysplasia and C-Reactive Protein in Smokers at High Risk of Lung Cancer Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 535 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. McGregor and M. J. Dunn Proteomics of the Heart: Unraveling Disease Circ. Res., February 17, 2006; 98(3): 309 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Silva, M. V. Gorenstein, G.-Z. Li, J. P. C. Vissers, and S. J. Geromanos Absolute Quantification of Proteins by LCMSE: A Virtue of Parallel ms Acquisition Mol. Cell. Proteomics, January 1, 2006; 5(1): 144 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Duncan and S. W. Hunsucker Proteomics as a Tool for Clinically Relevant Biomarker Discovery and Validation Experimental Biology and Medicine, December 1, 2005; 230(11): 808 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-J. Cheng, L.-C. Chen, K.-Y. Chien, Y.-J. Chen, J. T.-C. Chang, H.-M. Wang, C.-T. Liao, and I-H. Chen Oral Cancer Plasma Tumor Marker Identified with Bead-Based Affinity-Fractionated Proteomic Technology Clin. Chem., December 1, 2005; 51(12): 2236 - 2244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Hawkridge, D. M. Heublein, H. R. Bergen III, A. Cataliotti, J. C. Burnett Jr., and D. C. Muddiman Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure PNAS, November 29, 2005; 102(48): 17442 - 17447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Honda, Y. Hayashida, T. Umaki, T. Okusaka, T. Kosuge, S. Kikuchi, M. Endo, A. Tsuchida, T. Aoki, T. Itoi, et al. Possible Detection of Pancreatic Cancer by Plasma Protein Profiling Cancer Res., November 15, 2005; 65(22): 10613 - 10622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fitter and R. James Deconvolution of a Complex Target Using DNA Aptamers J. Biol. Chem., October 7, 2005; 280(40): 34193 - 34201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Xiao, W. Ying, L. Li, Z. Hu, Y. Ma, L. Jiao, J. Ma, Y. Cai, D. Lin, S. Guo, et al. An Approach to Studying Lung Cancer-related Proteins in Human Blood Mol. Cell. Proteomics, October 1, 2005; 4(10): 1480 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Anderson The Roles of Multiple Proteomic Platforms in a Pipeline for New Diagnostics Mol. Cell. Proteomics, October 1, 2005; 4(10): 1441 - 1444. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Lowenthal, A. I. Mehta, K. Frogale, R. W. Bandle, R. P. Araujo, B. L. Hood, T. D. Veenstra, T. P. Conrads, P. Goldsmith, D. Fishman, et al. Analysis of Albumin-Associated Peptides and Proteins from Ovarian Cancer Patients Clin. Chem., October 1, 2005; 51(10): 1933 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mian, S. Ugurel, E. Parkinson, I. Schlenzka, I. Dryden, L. Lancashire, G. Ball, C. Creaser, R. Rees, and D. Schadendorf Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients J. Clin. Oncol., August 1, 2005; 23(22): 5088 - 5093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Molina, J. Bunkenborg, G. H. Reddy, B. Muthusamy, P. J. Scheel, and A. Pandey A Proteomic Analysis of Human Hemodialysis Fluid Mol. Cell. Proteomics, May 1, 2005; 4(5): 637 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Qian, M. E. Monroe, T. Liu, J. M. Jacobs, G. A. Anderson, Y. Shen, R. J. Moore, D. J. Anderson, R. Zhang, S. E. Calvano, et al. Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach Mol. Cell. Proteomics, May 1, 2005; 4(5): 700 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Veenstra, T. P. Conrads, B. L. Hood, A. M. Avellino, R. G. Ellenbogen, and R. S. Morrison Biomarkers: Mining the Biofluid Proteome Mol. Cell. Proteomics, April 1, 2005; 4(4): 409 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chen, S. Pan, T. A. Brentnall, and R. Aebersold Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery Mol. Cell. Proteomics, April 1, 2005; 4(4): 523 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Wright, D. K. Han, and R. Aebersold Mass Spectrometry-based Expression Profiling of Clinical Prostate Cancer Mol. Cell. Proteomics, April 1, 2005; 4(4): 545 - 554. [Abstract] [Full Text] [PDF]
|
|
